Oscar Health Inc. Class A (OSCR) Financials
$29.31
As on 29-Sep-2026 13:42EDT
Market cap
$9,870 Mln
Revenue (TTM)
$15,319 Mln
P/E Ratio
24.8
P/B Ratio
4.9
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
15,318.63
|
11,701.43
|
9,177.56
|
5,862.87
|
4,125.58
|
1,920.96
|
|||||
|
Cost of Revenue
|
8,436.26
|
10,019.03
|
7,332.59
|
4,643.03
|
--
|
--
|
|||||
|
Gross Profit
|
6,882.38
|
1,682.40
|
1,844.98
|
5,862.87
|
4,125.58
|
1,920.96
|
|||||
|
Operating Expenses
|
6,258.28
|
2,078.76
|
1,787.71
|
6,098.48
|
4,735.66
|
2,491.54
|
|||||
|
Operating Profit (EBIT)
|
624.10
|
-396.36
|
57.27
|
-235.62
|
-610.08
|
-570.58
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
-21.38
|
|||||
|
Profit before Tax
|
589.81
|
-437.30
|
33.43
|
-267.30
|
-610.08
|
-570.58
|
|||||
|
Provision for Tax
|
38.88
|
5.61
|
7.31
|
3.29
|
-0.52
|
0.85
|
|||||
|
Profit after Tax (Net Income)
|
550.74
|
-443.15
|
25.43
|
-270.73
|
-606.28
|
-572.61
|
|||||
|
Minority Interest
|
-0.19
|
-0.25
|
-0.69
|
0.57
|
3.28
|
-1.18
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
-606.28
|
-572.61
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,052.03
|
977.65
|
1,013.59
|
803.97
|
890.38
|
1,387.23
|
|||||
|
Minority Interest
|
-0.19
|
--
|
--
|
--
|
2.02
|
5.29
|
|||||
|
Non-Current Liabilities
|
482.10
|
482.09
|
360.84
|
2,970.64
|
668.12
|
315.74
|
|||||
|
Current Liabilities
|
8,689.50
|
4,862.59
|
3,171.70
|
-175.28
|
2,966.08
|
1,617.50
|
|||||
|
Total Liabilities
|
19,916.26
|
6,325.41
|
4,840.50
|
3,601.48
|
4,526.60
|
3,321.65
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,853.58
|
1,712.01
|
1,995.32
|
1,529.90
|
384.01
|
555.65
|
|||||
|
Current Assets
|
9,373.19
|
4,613.40
|
2,845.17
|
2,071.58
|
4,142.59
|
2,762.22
|
|||||
|
Total Assets
|
20,599.95
|
6,325.41
|
4,840.50
|
3,601.48
|
4,526.60
|
3,321.65
|
|||||
|
Total Debt*
|
431.63
|
430.10
|
299.56
|
298.78
|
298.00
|
297.42
|
|||||
|
Net Current Assets
|
--
|
--
|
--
|
--
|
--
|
--
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,094.85
|
978.19
|
-272.16
|
380.35
|
-181.75
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-241.06
|
-1,387.43
|
577.19
|
-226.52
|
-774.52
|
|||||
|
Cash from Financing Activities
|
--
|
399.21
|
68.39
|
6.45
|
301.11
|
1,238.71
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
454.94
|
282.45
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
1.37
|
-1.56
|
0.10
|
-1.19
|
-2.82
|
-2.73
|
|||||
|
Cash EPS ($)
|
--
|
-1.46
|
0.22
|
-1.07
|
-2.75
|
-2.66
|
|||||
|
Adjusted Book Value ($)
|
--
|
3.45
|
3.81
|
3.54
|
4.14
|
6.61
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
3.87
|
3.68
|
-1.20
|
1.77
|
-0.87
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
3.74
|
3.57
|
-1.31
|
1.63
|
-0.99
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-32.57
|
2.11
|
-23.63
|
-42.20
|
-215.57
|
|||||
|
ROE (%)
|
36.34
|
-44.51
|
2.80
|
-31.96
|
-53.24
|
-1,253.85
|
|||||
|
ROA (%)
|
3.52
|
-7.94
|
0.60
|
-6.66
|
-15.45
|
-20.47
|
|||||
|
EBIT Margin (%)
|
3.95
|
-3.59
|
0.62
|
-4.02
|
-14.24
|
-29.46
|
|||||
|
Net Margin (%)
|
3.60
|
-3.79
|
0.28
|
-4.62
|
-14.70
|
-30.14
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
42.82
|
0.28
|
0.57
|
0.42
|
1.15
|
2.26
|
|||||
|
EBIT Growth (%)
|
574.33
|
-834.68
|
124.26
|
59.89
|
-3.82
|
-40.67
|
|||||
|
Net Profit Growth (%)
|
440.25
|
-1,842.49
|
109.39
|
55.35
|
-5.88
|
-40.75
|
|||||
|
EPS Growth (%)
|
283.19
|
-17.35
|
1.08
|
0.58
|
-0.03
|
0.80
|
|||||
|
Book Value Growth (%)
|
43.57
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
24.79
|
-9.18
|
140.49
|
-7.67
|
-0.87
|
-2.88
|
|||||
|
Price / Book Value
|
4.86
|
4.16
|
3.53
|
2.58
|
0.59
|
1.19
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
--
|
-1.30
|
19.27
|
0.78
|
3.72
|
-0.46
|
|||||
|
Close Price ($)
|
28.52
|
14.37
|
13.44
|
9.15
|
2.46
|
7.85
|
|||||
|
High Price ($)
|
30.66
|
23.80
|
23.79
|
9.89
|
10.53
|
37.00
|
|||||
|
Low Price ($)
|
10.69
|
11.20
|
8.44
|
2.35
|
2.05
|
7.51
|
|||||
|
Market Cap ($ Cr)
|
9,870.47
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.21
|
0.44
|
0.30
|
0.37
|
0.33
|
0.21
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
1.08
|
0.95
|
0.90
|
-11.82
|
1.40
|
1.71
|
|||||
|
Quick Ratio
|
1.08
|
--
|
--
|
-29.25
|
1.79
|
2.09
|
|||||
|
Interest Coverage
|
33.68
|
-23.86
|
2.41
|
-9.58
|
-25.97
|
-119.89
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
2.48
|
3.78
|
3.44
|
8.43
|
28.10
|
54.30
|
|||||
|
Asset Turnover
|
0.98
|
2.10
|
2.17
|
1.44
|
1.05
|
0.69
|
|||||
|
Receivable days
|
--
|
11.84
|
16.12
|
51.51
|
97.49
|
108.33
|
|||||
|
Inventory Days
|
--
|
--
|
-152.15
|
-165.74
|
--
|
--
|
|||||
|
Payable days
|
--
|
23.67
|
60.40
|
94.10
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
-196.43
|
-208.33
|
--
|
--
|